girentuximab,177lu-psma-618
novartis,heidelberg pharmaceuticals,esteve,prometheus
['lu177', 'rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', 'zircon', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'girentuximab', 'imab ']
positive phase 3 study new pet scan with 89zr-dfo-girentuximab for rcc presented by #gu23 lu177-girentuximab is the therapeutic version of antibody-radioisotope conjugate testing at 1l rcc #starlite1 
Medical Oncology Fellow, Physician-Scientist @MDAndersonNews